Huggies maker Kimberly-Clark is buying Tylenol maker Kenvue

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism, which the company is fighting.

Kimberly-Clark to acquire Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.

Kleenex Wipes Away Kenvue’s Tears: North Texas’ Kimberly-Clark To Buy Embattled Tylenol Maker

Irving-based Kimberly-Clark snaps up Tylenol maker Kenvue in a cash-and-stock blockbuster, uniting Kleenex, Huggies, and Band-Aid.

Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here's background, current challenges, future outlook ...

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion. The cash-and-stock deal will merge brands like Huggies, Kleenex, Tylenol, and Band-Aid under one company,

Kimberly-Clark Tanks on Deal to Buy Tylenol Maker Kenvue

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, Tylenol, is in the crosshairs of the White House.

Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.

Irving-based Kimberly-Clark buys Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue Inc., a personal care
Feedback